NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN)
ACHN Technical Analysis
3
As on 31st Oct 2017 ACHN Share Price closed @ 4.02 and we RECOMMEND Sell for LONG-TERM with Stoploss of 4.21 & Sell for SHORT-TERM with Stoploss of 4.42 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ACHN Share Price
Open | 4.09 | Change | Price | % |
High | 4.18 | 1 Day | -0.04 | -0.99 |
Low | 3.98 | 1 Week | 0.00 | 0.00 |
Close | 4.02 | 1 Month | -0.57 | -12.42 |
Volume | 855091 | 1 Year | -0.65 | -13.92 |
52 Week High 5.66 | 52 Week Low 3.15 |
NASDAQ USA Most Active Stocks
YHOO | 52.58 | 0.00% |
FNFG | 10.18 | -0.20% |
DELL | 13.86 | 0.22% |
RFMD | 16.59 | -2.07% |
MU | 44.31 | 6.39% |
RIMM | 13.03 | 0.39% |
BBEP | 0.12 | 0.00% |
GTAT | 0.44 | 0.00% |
SUSQ | 14.20 | -0.77% |
INTC | 45.49 | 2.52% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
ACHN Daily Charts |
ACHN Intraday Charts |
Whats New @ Bazaartrend |
ACHN Free Analysis |
|
ACHN Important Levels Intraday
SUPPORT | 0.00 |
SUPPORT | 0.00 |
RESISTANCE | 4.21 |
RESISTANCE | 4.13 |
SUPPORT | 3.91 |
SUPPORT | 3.83 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
ACHN Target for Month January
4th UP TARGET | 6.29 |
3rd UP TARGET | 5.56 |
2nd UP TARGET | 5.11 |
1st UP TARGET | 4.66 |
1st DOWN TARGET | 3.38 |
2nd DOWN TARGET | 2.93 |
3rd DOWN TARGET | 2.48 |
4th DOWN TARGET | 1.75 |
ACHN Weekly Target
4th UP TARGET | 0.00 |
3rd UP TARGET | 0.00 |
2nd UP TARGET | 0.00 |
1st UP TARGET | 0.00 |
1st DOWN TARGET | 0.00 |
2nd DOWN TARGET | 0.00 |
3rd DOWN TARGET | 0.00 |
4th DOWN TARGET | 0.00 |
ACHN Target for Year 2021
4th UP TARGET | 0 |
3rd UP TARGET | 0 |
2nd UP TARGET | 0 |
1st UP TARGET | 0 |
1st DOWN TARGET | 0 |
2nd DOWN TARGET | 0 |
3rd DOWN TARGET | 0 |
4th DOWN TARGET | 0 |
Achillion Pharmaceuticals, Inc. ( NASDAQ USA Symbol : ACHN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ACHN Other Details
Segment | EQ | |
Market Capital | 720848960.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
ACHN Address
![]() |
300 George Street New Haven, CT 06511 United States Phone: 203-724-6000 Fax: 203-624-7003 |
ACHN Latest News
ACHN Business Profile
Achillion Pharmaceuticals, Inc., incorporated on August 17, 1998, is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases.
The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the treatment of resistant bacterial infections.
The Company focuses on the development of four drug candidates for the treatment of HCV: ACH-1625, a NS3 protease inhibitor for the treatment of HCV, which is being tested in a phase IIa clinical trial, ACH-2684, a NS3 protease inhibitor for the treatment of HCV, which is being tested in a phase I clinical trial; ACH-2928, a NS5A inhibitor for the treatment of HCV, which is being tested in a phase I clinical trial, and ACH-3102, a NS5A inhibitor for the treatment of HCV, which is being prepared for investigational new drug (IND), filing and initiation of a phase I clinical trial.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service